Coya Therapeutics, Inc. Common Stock

Go to Coya Therapeutics, Inc. Common Stock Website

$6.74

0.31 (4.82%)
Live
Previous Close

$6.43

Day Range

$0 - $0

Previous Day Range

$6.25 - $6.5

Market Cap

$106.0 million USD

Day Vol.

0

Previous Day Vol.

20305

Currency

USD

Primary Exchange

Nasdaq

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune,...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Dr. Reddy's (RDY) enters into a licensing agreement with Coya Therapeutics to develop and commercialize the latter's ALS investigational combination therapy, COYA 302.

Related tickers: RDY, AGEN, PBYI, COYA.

Read Full Article

We've compiled a list of August investment picks that you may have missed. Some Seeking Alpha analysts are more discerning by nature. See their Buy recommendations here.

Related tickers: FSI, BDTX, TDOC, LEVI, VTR, NVDA, EXPI, AZO, CFG, FOUR, MSGS, VTS, ATUS, HSY, GSM, X, TPYP, TACT, MP, CRM, ARLO, LOW, PYPL, NDLS, PH, SMIN, DCTH, HOOD, COYA, CHWY.

Read Full Article
Trending Tickers

Please sign in to view